CN Patent

CN116456970A — 包括氘代丁苯那嗪的胃滞留剂型

Assigned to Ospex Pharmaceuticals · Expires 2023-07-18 · 3y expired

What this patent protects

本文提供了用于治疗例如多动性运动障碍的含有氘代丁苯那嗪的控释胃滞留剂型。当按每日一次向受试者口服施用时，所述剂型提供了有利的药代动力学特征。

USPTO Abstract

本文提供了用于治疗例如多动性运动障碍的含有氘代丁苯那嗪的控释胃滞留剂型。当按每日一次向受试者口服施用时，所述剂型提供了有利的药代动力学特征。

Drugs covered by this patent

Patent Metadata

Patent number
CN116456970A
Jurisdiction
CN
Classification
—
Expires
2023-07-18
Drug substance claim
No
Drug product claim
No
Assignee
Ospex Pharmaceuticals
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.